Chemotherapy with low-dose bevacizumab and carboplatin in the treatment of a patient with recurrent cervical cancer
Tan, S.J.; Juan, Y.H.; Fu, P.T.; Yu, M.H.; Lai, H.C.
European Journal of Gynaecological Oncology 31(3): 350-353
2010
ISSN/ISBN: 0392-2936 PMID: 21077488 Document Number: 638257
Management of patients with recurrent or advanced cervical cancer is a challenge. Concurrent chemotherapy has become the mainstay of treatment and platinum remains the most effective single agent. Combinations of other agents have not demonstrated significant advantages. The application of angiogenesis inhibitors such as bevacizumab, an antibody inhibiting vascular endothelial growth factor, in metastatic or advanced cervical cancer remains to be evaluated. We present the case of a patient with platinum-resistant recurrent cervical cancer treated with low-dose bevacizumab and carboplatin, with resultant improved disease progression and tolerable toxicity profiles.
Document emailed within 1 workday
Related Documents
Kaira, K.; Ishizuka, T.; Yanagitani, N.; Sunaga, N.; Hisada, T.; Mori, M. 2007: Effective combination chemotherapy of carboplatin and paclitaxel in the treatment of a recurrent small-cell lung cancer patient Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(2): 225-227Shigoka, M.; Enomoto, M.; Wada, T.; Mazaki, J.; Kuwabara, H.; Ishizaki, T.; Ishibashi, Y.; Nagakawa, Y.; Katsumata, K.; Tsuchida, A. 2019: A Case of a Patient with Locally Recurrent Rectal Cancer Who Underwent Surgical Resection after Chemotherapy with FOLFOXIRI plus Bevacizumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(4): 796-798
Soga, Y.; Ito, D.; Asano, H.; Go, M.; Iwai, M.; Okada, K.; Matsuoka, T.; Adachi, S.; Usami, E.; Kimura, M.; Nakao, T.; Yoshimura, T.; Yasuda, T.; Ogawa, T.; Iwaki, A. 2013: Continuation of chemotherapy with bevacizumab for advanced and recurrent colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(10): 1341-1345
Vapattanawong, P. 2006: A comparative study on hematological effects of carboplatin plus cyclophosphamide and carboplatin plus paclitaxel chemotherapy for the first line treatment of epithelial ovarian cancer Journal of the Medical Association of Thailand 89(9): 1357-1361
Ozet, A.; Yavuz, A.A.; Oztürk, B.; Kömürcü, S.; Arpaci, F.; Tuvay, E.; Tezcan, Y. 2000: Recurrent spontaneous pneumothorax following high-dose chemotherapy in a patient with non-seminomatous testicular cancer with pulmonary metastases Tumori 86(3): 253-255
Koda, T.; Koike, J.; Masuhara, H.; Kurihara, A.; Shiokawa, H.; Ushigome, M.; Kaneko, T.; Suzuki, T.; Sawaguchi, Y.; Katayanagi, T.; Fujii, T.; Watanabe, Y.; Funahashi, K.; Shimada, H.; Kaneko, H. 2016: A Case of Aortoesophageal Fistula Rupture Due to Descending Thoracic Aortic Dissection with Recurrent Colon Cancer during Chemotherapy Containing Bevacizumab Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 1815-1817
Yabe, N.; Murai, S.; Shimizu, H.; Kitasato, K.; Yoshikawa, T.; Oto, I.; Nakadai, J.; Hasegawa, H.; Kitagawa, Y. 2013: Recurrent rectal cancer with multiple liver and lung metastases treated effectively with oxaliplatin and capecitabine plus bevacizumab chemotherapy-a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 1834-1836
Suwannarurk, K.; Thaweekul, Y.; Mairaing, K.; Poomtavorn, Y.; Tangtiang, K.; Piyawang, W.; Bhamarapravatana, K. 2015: Bevacizumab, Carboplatin and Paclitaxel Combination Treatment in Advanced Stage Ovarian Cancer: The First Experience in Thammasat University Hospital, Thailand: A Case Report Journal of the Medical Association of Thailand 98 Suppl. 3: S121-S125
Maki, S.; Igawa, S.; Otani, S.; Nagashima, Y.; Kimura, M.; Hiyoshi, Y.; Ishihara, M.; Kasajima, M.; Katono, K.; Takakura, A.; Kubota, M.; Masuda, N. 2012: Efficacy of chemotherapy with carboplatin-paclitaxel plus bevacizumab for previously treated patients with advanced non-small cell carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(13): 2509-2512
Shimizu, Y.; Nakayama, K.; Seimiya, Y.; Yamakawa, Y.; Koi, S.; Yokosuka, K.; Teshima, H.; Chen, J.T.; Fujimoto, I.; Yamauchi, K. 1991: Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin Nihon Sanka Fujinka Gakkai Zasshi 43(5): 549-556
Takeda, T.; Miyake, M.; Tanaka, K.; Uemura, M.; Ikeda, M.; Maeda, S.; Yamamoto, K.; Hama, N.; Nishikawa, K.; Miyamoto, A.; Miyazaki, M.; Hirao, M.; Nakamori, S.; Sekimoto, M. 2015: XELOX plus Bevacizumab Chemotherapy for a Patient with Postoperative Recurrence of Colorectal Cancer Under Hemodialysis for Chronic Renal Failure Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 1594-1596
Akers, S.N.; Riebandt, G.; Miller, A.; Groman, A.; Odunsi, K.; Lele, S. 2013: Bevacizumab for the treatment of recurrent ovarian cancer: a retrospective cohort study European Journal of Gynaecological Oncology 34(2): 113-119
Kashiwagi, S.; Ishihara, S.; Ishii, M.; Asano, Y.; Watanabe, M.; Morisaki, T.; Aomatsu, N.; Noda, S.; Kawajiri, H.; Nakano, T.; Kawakami, N.; Mitsukawa, Y.; Takashima, T.; Onoda, N.; Ishikawa, T.; Hirakawa, K. 2013: Case of a patient with inflammatory breast cancer who responded to preoperative chemotherapy with paclitaxel plus bevacizumab and could subsequently undergo surgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 2384-2386
Mitsugi, K.; Yasutake, T.; Etoh, T.; Ishimaru, T.; Ueda, A.; Nakano, S.; Niho, Y. 1993: Successful treatment of recurrent multiple lung metastasis from colon cancer with combination chemotherapy using methotrexate, 5-fluorouracil, and high-dose leucovorin: a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2387-2390
Yokoyama, Y.; Shigeto, T.; Futagami, M.; Mizunuma, H. 2005: Syndrome of inappropriate secretion of anti-diuretic hormone following carboplatin-paclitaxel administration in a patient with recurrent ovarian cancer European Journal of Gynaecological Oncology 26(5): 531-532
Ishiura, Y.; Yamamoto, H.; Terasaki, Y.; Ishida, Y.; Tohge, M.; Segawa, M.; Kusajima, Y.; Saitoh, K.; Ishikawa, M.; Hirokami, N.; Kasahara, K.; Fujimura, M. 2011: Bevacizumab with platinum chemotherapy as 6th-line treatment in a case of non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2631-2633
Hama, M.; Komatsu, Y.; Hachiya, T. 2011: A case of lung cancer showing marked reduction of pleural effusion by bevacizumab in combination with carboplatin and paclitaxel Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(11): 1877-1879
Ozols, R.F. 2000: Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer Seminars in Oncology 27(3 Suppl 7: 3-7
Prueksaritanond, N.; Chaisarn, P.; Yanaranop, M. 2012: The efficacy of neoadjuvant paclitaxel-carboplatin chemotherapy followed by radical hysterectomy compared to radical hysterectomy alone in bulky stage IB2-IIA cervical cancer Journal of the Medical Association of Thailand 95(Suppl 3): S55-S61
Skarlos, D.V.; Aravantinos, G.; Kosmidis, P.; Athanassiadis, A.; Stathopoulos, G.P.; Pavlidis, N.; Bafaloukos, D.; Karphathios, S.; Papakostas, P.; Bamia, C.; Fountzilas, G. 1997: Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study Seminars in Oncology 24(5 Suppl 15: S15